VITA 34 International AG increases revenues in Q1 200, setting the course for further growth

VITA 34 International AG / Quarter Results

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
The issuer / publisher is solely responsible for the content of this announcement.

• Revenues of EUR 3.6 million. 
• EBIT of EUR -0.3 million as planned 
• Period result in the group of EUR 0.1 million. 
• Clearly upturn in international revenues planned.
Leipzig, Germany, April 14,2008 - Revenues of VITA 34 International AG
(ISIN DE000A0BL849), as the holding of the leading company for storing
umbilical cord blood in Germany, VITA 34, rose to EUR 3.6 million in Q1
2008 following EUR 3.5 million in the equivalent period of the previous
year. VITA 34 thus looks back on its best first quarter in the more than
ten years of the company’s history. The number of stored stem cell
preparations totaled 2,453 as compared to 2,446 in the strong prior year

Due to the scheduled 40% increase in expenditure for sales and marketing,
EBIT from continued operations amounted to EUR -0.3 million compared with
EUR 0.3 million one year before. At EUR 0.1 million, the group result
including discontinued operations was slightly positive. In Q1 of the
previous year, profit from the discontinued operation amounting to EUR 1.3
million resulted in a net result of EUR 1.4 million.

The equity ratio of the group rose steadily, reaching 64%, three percentage
points more than on December 31, 2007

VITA 34 anticipates that the new marketing and sales strategy which started
in the previous year will make an increasing impact from the middle of
2008, in line with planning. As the undisputed market leader in the
German-speaking countries, VITA 34 plans a clear, strong increase in
international operating revenues in the current year. One factor making a
contribution here is the very successful partnership with the Spanish
company, Secuvita
14.04.2008  Financial News transmitted by DGAP
Language:     English
Issuer:       VITA 34 International AG
              Deutscher Platz 5a
              04103 Leipzig
Phone:        +49(0341)48792-40
Fax:          +49(0341)48792-39
ISIN:         DE000A0BL849
WKN:          A0BL84
End of News                                     DGAP News-Service